- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Multiple Myeloma, Refractory in New Zealand
Total 2647 results
-
Piramal Enterprises LimitedCompletedRelapsed and/or Refractory Multiple MyelomaIndia
-
AbbVieRecruitingRelapsed/Refractory Multiple MyelomaUnited States, Australia, Israel, United Kingdom
-
Altor BioScienceNational Cancer Institute (NCI)UnknownRelapsed or Refractory Multiple MyelomaUnited States
-
Indapta Therapeutics, INC.RecruitingMultiple Myeloma | Refractory Multiple Myeloma | Refractory Non-Hodgkin Lymphoma | NHL | Blood Cancer | Relapsed Multiple Myeloma | Relapsed Non-Hodgkin LymphomaUnited States
-
Caribou Biosciences, Inc.RecruitingRelapsed/Refractory Multiple MyelomaUnited States
-
Juno Therapeutics, Inc., a Bristol-Myers Squibb...RecruitingRelapsed and/or Refractory Multiple MyelomaUnited States, France, Spain, Germany
-
Ichnos Sciences SARecruitingRelapsed/Refractory Multiple MyelomaUnited States, Australia
-
GenmabRecruitingAcute Myeloid Leukemia (AML) | Diffuse Large B Cell Lymphoma (DLBCL) | Relapsed or Refractory Multiple Myeloma (RRMM)United States, Korea, Republic of, Netherlands, Denmark, Australia, New Zealand, Poland, Spain, Sweden, Czechia, Malaysia, Greece, Moldova, Republic of, Georgia, Ukraine, France, Hungary, North Macedonia, Bosnia and Herzegovina and more
-
Cellectis S.A.TerminatedRelapsed/Refractory Multiple MyelomaUnited States
-
Kite, A Gilead CompanyTerminatedRelapsed/Refractory Multiple MyelomaUnited States
-
Allogene TherapeuticsActive, not recruitingRelapsed/Refractory Multiple MyelomaUnited States
-
Albert Einstein College of MedicineNational Cancer Institute (NCI)TerminatedRefractory Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell Myeloma | DS (Durie/Salmon) Stage I Plasma Cell MyelomaUnited States
-
AmgenTerminatedRelapsed and/or Refractory Multiple MyelomaUnited States, Japan, Belgium, Australia, Switzerland
-
AbbVieGenentech, Inc.CompletedRelapsed/Refractory Multiple MyelomaUnited States, Belgium, France, Norway
-
Xencor, Inc.TerminatedRelapsed/ Refractory Multiple MyelomaUnited States, Australia
-
ORIC PharmaceuticalsRecruitingRelapsed or Refractory Multiple MyelomaUnited States, Canada
-
Roswell Park Cancer InstituteBristol-Myers SquibbActive, not recruitingRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
AmgenCompletedRelapsed or Refractory Multiple MyelomaUnited States, Belgium, Australia, Spain, Canada, Netherlands
-
AmgenTerminatedRelapsed/Refractory Multiple MyelomaUnited States, Australia, Japan, Germany, Netherlands, Canada
-
TeneoOne Inc.RecruitingRelapsed/Refractory Multiple MyelomaAustralia, Germany, Japan, Spain, United States, Italy, Poland
-
Academic and Community Cancer Research UnitedNational Cancer Institute (NCI)RecruitingRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Oncopeptides ABApproved for marketingRelapsed and/or Refractory Multiple MyelomaUnited States
-
Celyad Oncology SAUnknownAcute Myeloid Leukemia/Myelodysplastic Syndrome | Multiple Myeloma (MM)United States, Belgium
-
SanofiActive, not recruitingRelapsed/Refractory Multiple MyelomaAustralia, Czechia, Brazil, Japan, Greece, Portugal
-
ModernaTX, Inc.WithdrawnRelapsed or Refractory Multiple MyelomaUnited States, Canada
-
TakedaTerminatedRelapsed and/or Refractory Multiple Myeloma (RRMM)United States, Canada
-
Janssen Research & Development, LLCRecruitingRelapsed/ Refractory Multiple MyelomaUnited States, Germany, Spain, France
-
CelgeneRecruitingRelapsed or Refractory Multiple MyelomaUnited States, Australia, Italy, China, Spain, Germany, Romania, Korea, Republic of, Japan, United Kingdom, Czechia, Finland, France, Greece, Argentina, Belgium, Austria, Portugal, Israel, Poland, Brazil, Turkey, Canada, Ireland, New Zealand and more
-
Incyte CorporationTerminatedRelapsed or Refractory Multiple MyelomaUnited States, Spain, Germany
-
SanofiRecruitingPlasma Cell Myeloma RefractoryFrance, Australia, Greece, Italy, Norway, United States, Portugal, Puerto Rico, Germany
-
National Cancer Institute (NCI)Terminated
-
Aptose Biosciences Inc.RecruitingRelapsed or Refractory Acute Myeloid LeukemiaUnited States, Germany, Spain, Korea, Republic of, Australia, New Zealand
-
Regeneron PharmaceuticalsRecruitingRelapsed Refractory Multiple Myeloma (RRMM)Canada, United States, Korea, Republic of, Israel, Taiwan, Spain, Australia, Brazil, France, United Kingdom, Poland, Singapore, Netherlands, Italy
-
AmgenTerminatedRelapsed or Refractory Multiple MyelomaUnited States
-
Janssen Research & Development, LLCRecruitingRelapsed or Refractory Multiple MyelomaUnited States, Italy, Korea, Republic of, Taiwan, China, Germany, Turkey, Japan, France, United Kingdom, Brazil, Spain, Czechia, Israel, Belgium, Greece, Poland, Netherlands
-
Fate TherapeuticsTerminatedAcute Myeloid Leukemia | Multiple Myeloma | Myeloma | AML, AdultUnited States
-
AmgenActive, not recruitingRelapsed or Refractory Multiple MyelomaUnited States, Spain, Germany, France, Italy, Denmark, Greece, Estonia
-
Cleave Biosciences, Inc.TerminatedLymphoid Hematological Malignancies | Relapsed and Refractory Multiple MyelomaCanada, United States
-
Memorial Sloan Kettering Cancer CenterRecruitingAcute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Acute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia Refractory | Relapsed Acute Myeloid LeukemiaUnited States
-
Janssen Research & Development, LLCRecruitingRelapsed or Refractory Multiple MyelomaUnited States, Canada, Australia, China, Germany, Belgium, Malaysia, Turkey, Israel, Sweden, Spain, United Kingdom, Czechia, Denmark, Brazil, Italy, France, Japan, Netherlands, Poland, Austria, Portugal, Greece, India
-
Bristol-Myers SquibbRecruitingRelapsed or Refractory Multiple MyelomaUnited States, Austria, Denmark, Canada, Australia, China, Spain, Germany, United Kingdom, Hungary, Taiwan, Israel, Japan, India, Norway, Brazil, Italy, Greece, Korea, Republic of, Colombia, Singapore, Netherlands, Argentina, Hong Kong, Romani... and more
-
National Cancer Institute (NCI)TerminatedStage II Multiple Myeloma | Stage III Multiple MyelomaUnited States
-
AbbVieGenentech, Inc.CompletedRelapsed/Refractory Multiple MyelomaUnited States, Australia, Brazil, Canada, France, Germany, Hungary, Ireland, Italy, Japan, Korea, Republic of, Russian Federation, Spain, Taiwan, Ukraine, United Kingdom
-
Roswell Park Cancer InstituteCompletedAcute Myeloid Leukemia | Chronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | Alkylating Agent-Related Acute Myeloid Leukemia | Refractory Anemia With Excess Blasts in TransformationUnited States
-
Icahn School of Medicine at Mount SinaiPharmacyclics LLC.TerminatedHigh Risk Smoldering Multiple MyelomaUnited States
-
Memorial Sloan Kettering Cancer CenterHealthTree FoundationRecruitingMultiple Myeloma, SmolderingUnited States
-
Novartis PharmaceuticalsCompletedRelapsed or Refractory Multiple MyelomaUnited States, Turkey, Canada, Netherlands, Australia, Germany, France
-
AmgenCompletedRelapsed or Refractory Multiple MyelomaFrance, Czechia, Sweden, United States, Greece, Spain, Finland, Romania, Germany, Japan, Netherlands, Turkey, Austria, Bulgaria, Lithuania, Russian Federation, Slovakia
-
Memorial Sloan Kettering Cancer CenterMillennium Pharmaceuticals, Inc.CompletedMultiple Myeloma | High Risk Smoldering Multiple MyelomaUnited States
-
Millennium Pharmaceuticals, Inc.CompletedRelapsed and/or Refractory Multiple MyelomaUnited States, France, Norway, Spain, Israel, United Kingdom, Italy, Australia, Germany, Greece, Canada, Czechia, Turkey, Russian Federation, Denmark, Sweden, Belgium, Netherlands